Skip to main content
George Weiner, MD, Oncology, Iowa City, IA, University of Iowa Hospitals and Clinics

GeorgeJWeinerMD

Oncology • Iowa City, IA

Hematologic Oncology

Professor of Medicine, University Iowa College of Medicine

Join to view full profile

Dr. Weiner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Weiner's full profile

Already have an account?

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 1985 - 1989
  • University of Toledo
    University of ToledoResidency, Internal Medicine, 1981 - 1985
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1981

Certifications & Licensure

  • IA State Medical License
    IA State Medical License 1989 - 2026
  • MI State Medical License
    MI State Medical License 1987 - 1991
  • OH State Medical License
    OH State Medical License 1984 - 1986
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Iowa Governor Sides with Anti-Vaxxers, Not Cancer Experts
    Iowa Governor Sides with Anti-Vaxxers, Not Cancer ExpertsMarch 6th, 2023
  • Bleeding Heartland
    Bleeding HeartlandMarch 6th, 2023
  • Iowa’s Cancer Battle: More People Are Surviving
    Iowa’s Cancer Battle: More People Are SurvivingMarch 1st, 2023
  • Join now to see all

Grant Support

  • Tumor ImagingNational Cancer Institute2011–2012
  • Staff InvestigatorsNational Cancer Institute2011–2012
  • Shared Resources - Tissue ProcurementNational Cancer Institute2011–2012
  • Shared Resources - Small Animal ImagingNational Cancer Institute2011–2012
  • Shared Resources - Gene Transfer Vector CoreNational Cancer Institute2011–2012
  • Shared Resources - Flow Cytrometry CoreNational Cancer Institute2011–2012
  • Shared Resources - DNA CoreNational Cancer Institute2011–2012
  • Shared Resources - Central Microscopy Research FacilityNational Cancer Institute2011–2012
  • Shared Resources - BioinformaticsNational Cancer Institute2011–2012
  • Shared Resources - Radiation And Free Radical Research CoreNational Cancer Institute2011–2012
  • Protocol Specific Research SupportNational Cancer Institute2011–2012
  • Protocol Review Monitoring CommitteeNational Cancer Institute2011–2012
  • Program Signaling And Experimental TherapeuticsNational Cancer Institute2011–2012
  • Population Research CoreNational Cancer Institute2011–2012
  • Free Radical Cancer BiologyNational Cancer Institute2011–2012
  • Data And Safety MonitoringNational Cancer Institute2011–2012
  • Clinical Trials Support CoreNational Cancer Institute2011–2012
  • Cancer Immunology And ImmunotherapyNational Cancer Institute2011–2012
  • Cancer Genomics And Cell GrowthNational Cancer Institute2011–2012
  • Cancer EpidemiologyNational Cancer Institute2011–2012
  • BiostatisticsNational Cancer Institute2011–2012
  • AdministrationNational Cancer Institute2011–2012
  • Planning And EvaluationNational Cancer Institute2009–2012
  • Senior LeadershipNational Cancer Institute2005–2012
  • Developmental FundsNational Cancer Institute2005–2012
  • Cancer Center Support Grant (CCSG)National Cancer Institute2000–2012
  • P1 - A Novel Approach To The Immunotherapy Of B Cell MalignancyNational Cancer Institute2010–2011
  • Monoclonal Antibody-Induced NK Cell Activation And ComplementNational Cancer Institute2009–2011
  • Lymphoma Specialized Program Of Research Excellence (SPORE)National Cancer Institute2007–2011
  • Administrative CoreNational Cancer Institute2009
  • A Novel Approach To The Immunotherapy Of B Cell MalignancyNational Cancer Institute2007–2009
  • AdministrationNational Cancer Institute2007
  • CPG ODN As An Immune AdjuvantNational Cancer Institute2003–2006
  • Lymphoma Specialized Program Of Research ExcellenceNational Cancer Institute2002–2006
  • Planning &EvaluationNational Cancer Institute2005
  • Institutional National Research Service Award (T32)National Cancer Institute2000–2004
  • Mechanism Of Action Of Anti-Hla-Dr AntibodyNational Cancer Institute2002
  • Hum195 For Refractory Or Relapsed Acute Myelogenous LeukemiaNational Center For Research Resources1999–2002
  • CPG ODN As An Adjuvant In Tumor ImmunizationNational Cancer Institute1999–2001
  • Hum195 Maintenance Therapy In Elderly Patients With Acute Myelogenous LeukemiaNational Center For Research Resources1997–2000
  • Bispecific Antibody Therapy Of B Cell LymphomaNational Cancer Institute1997–2000
  • Anticd20 Mediated Signaling And Antitumor ResponseNational Cancer Institute1997–1998
  • Bispecific Antibody Therapy Of B-Cell LymphomaNational Cancer Institute1992–1996
  • Bispecific Antibody Therapy Of B-Cell LymphomaNational Cancer Institute1991
  • ImmunologyNational Cancer Institute1989
  • Antibody-Armed Effector Cell Therapy Of B-Cell LymphomaNational Cancer Institute1988

Professional Memberships

Hospital Affiliations

Dr. George Weiner, Dr. George Weiner, MD, Dr. G Weiner, Dr. George J Weiner